Aprea Therapeutics Earnings Estimate

APRE Stock  USD 0.95  0.02  2.15%   
By analyzing Aprea Therapeutics' earnings estimates, investors can diagnose different trends across Aprea Therapeutics' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Aprea Therapeutics is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Aprea Therapeutics is projected to generate -0.49 in earnings per share on the 31st of December 2025. Aprea Therapeutics earnings estimates show analyst consensus about projected Aprea Therapeutics EPS (Earning Per Share). It derives the highest and the lowest estimates based on Aprea Therapeutics' historical volatility. Many public companies, such as Aprea Therapeutics, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Aprea Therapeutics' earnings estimates, investors can diagnose different trends across Aprea Therapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. The current year's Gross Profit Margin is expected to grow to 1.09, whereas Gross Profit is projected to grow to (7.5 M). Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aprea Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Aprea Stock refer to our How to Trade Aprea Stock guide.

Aprea Therapeutics Earnings per Share Projection vs Actual

About Aprea Therapeutics Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Aprea Therapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Aprea Therapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Aprea Therapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-321 M-305 M
Retained Earnings Total Equity-129.6 M-123.1 M
Earnings Yield(0.71)(0.75)
Price Earnings Ratio(1.40)(1.47)
Price Earnings To Growth Ratio 0.03  0.04 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Aprea Therapeutics is a strong investment it is important to analyze Aprea Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aprea Therapeutics' future performance. For an informed investment choice regarding Aprea Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aprea Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Aprea Stock refer to our How to Trade Aprea Stock guide.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aprea Therapeutics. If investors know Aprea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aprea Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.12)
Revenue Per Share
0.08
Quarterly Revenue Growth
(0.99)
Return On Assets
(0.42)
Return On Equity
(0.75)
The market value of Aprea Therapeutics is measured differently than its book value, which is the value of Aprea that is recorded on the company's balance sheet. Investors also form their own opinion of Aprea Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Aprea Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aprea Therapeutics' market value can be influenced by many factors that don't directly affect Aprea Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aprea Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Aprea Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aprea Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.